| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
04-04-2017, 09:13 PM
|
#10 | ||
|
|||
|
Member
|
Blackfeather said: ".... an aggegation of alpha synuclean in the brain results in PD."
It is my understanding that this has not (yet) been proven, although it is fairly safe to say that an aggregation of alpha synuclein in the brain is associated with PD. As Tupelo3 said: "Let's just hope that it actually has efficacy." IMHO, they might end up (eventually) finding that PD results in an aggregation of alpha synuclein in the brain, rather then an aggregation of alpha synuclein in the brain results in PD. |
||
|
 Reply With Quote
|
| "Thanks for this!" says: | Tupelo3 (04-04-2017) |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Prothena reports 97 % reduction of alpha synuclein after 1 dose! | Parkinson's Disease | |||
| Study Refutes Prion Theory of Alpha-Synuclein Aggregates in Parkinson's Disease | Parkinson's Disease | |||
| Prothena initiates 2nd phase 1 study of PRX002 - another A-Syn antibody | Parkinson's Disease | |||
| First human dosed in Phase 1 trial of antibody targeting alpha synuclein | Parkinson's Disease | |||
| Alpha-synuclein | Parkinson's Disease | |||
Threaded Mode